sábado, 14 de junio de 2025

HER2+: Which First-Line Combo Wins? ++++ +++ +++

Treatment Advances & Patient Outcomes HER2+: Which First-Line Combo Wins? https://www.medscape.com/viewarticle/which-first-line-tx-combo-best-her2-breast-cancer-2025a1000fb8?ecd=mkm_ret_250614_mscpmrk_onc_breast_etid7494413&uac=148436CN&impID=7494413 Vepdegestrant Doubles PFS vs Fulvestrant in ESR1+ Disease https://www.medscape.com/viewarticle/which-class-er-degrader-better-er-her2-breast-cancer-2025a1000eqw?ecd=mkm_ret_250614_mscpmrk_onc_breast_etid7494413&uac=148436CN&impID=7494413 Can Early Switch to Camizestrant Beat Resistance? https://www.medscape.com/viewarticle/catching-resistance-early-can-switching-camizestrant-help-2025a1000f68?ecd=mkm_ret_250614_mscpmrk_onc_breast_etid7494413&uac=148436CN&impID=7494413 Musical Toxicity After Breast Cancer Treatment https://www.medscape.com/viewarticle/musicians-face-lasting-side-effects-after-breast-cancer-2025a1000dt5?ecd=mkm_ret_250614_mscpmrk_onc_breast_etid7494413&uac=148436CN&impID=7494413 Screening & Prevention Olive Oil Tied to Lower Breast Cancer Risk https://www.medscape.com/viewarticle/olive-oil-may-cut-risk-specific-breast-cancer-types-2025a1000e33?ecd=mkm_ret_250614_mscpmrk_onc_breast_etid7494413&uac=148436CN&impID=7494413 New Imaging Triples Dense Breast Cancer Detection https://www.medscape.com/viewarticle/new-imaging-triples-dense-breast-cancer-detection-2025a1000d7j?ecd=mkm_ret_250614_mscpmrk_onc_breast_etid7494413&uac=148436CN&impID=7494413 3D Mammography: Better for High-Risk Women? https://www.medscape.com/viewarticle/mammography-better-women-family-history-breast-cancer-2025a1000e0o?ecd=mkm_ret_250614_mscpmrk_onc_breast_etid7494413&uac=148436CN&impID=7494413 US Drug Spotlight Abemaciclib https://reference.medscape.com/drug/verzenio-abemaciclib-1000194?ecd=mkm_ret_250614_mscpmrk_onc_breast_etid7494413&uac=148436CN&impID=7494413 Trastuzumab Deruxtecan https://reference.medscape.com/drug/enhertu-trastuzumab-deruxtecan-4000032?ecd=mkm_ret_250614_mscpmrk_onc_breast_etid7494413&uac=148436CN&impID=7494413 Sacituzumab Govitecan https://reference.medscape.com/drug/trodelvy-sacituzumab-govitecan-1000280?ecd=mkm_ret_250614_mscpmrk_onc_breast_etid7494413&uac=148436CN&impID=7494413

No hay comentarios:

Publicar un comentario